Journals / Kocatepe Tıp Dergisi / 2026 / Cilt: 27 Sayı: 2

EVALUATION OF THE EXPERIENCE AND KNOWLEDGE LEVELS OF DENTISTS ABOUT ANAPHYLAXIA AND TREATMENT, SURVEY STUDY

DİŞ HEKİMLERİNİN ANAFİLAKSİ VE TEDAVİSİ HAKKINDAKİ DENEYİM VE BİLGİ DÜZEYLERİNİN DEĞERLENDİRİLMESİ, ANKET ÇALIŞMASI

Yasemin Akçaalan(ANKARA ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ)0000-0003-0011-3489
Boran Yıldız(ANKARA ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ)0009-0008-5255-452X
Çağla Özkaranfil(ANKARA ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ)0009-0003-9971-6737
İlknur Açıkmeşe(ANKARA ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ)0009-0002-4319-264X
Kaan Orhan(ANKARA ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ)0000-0001-6768-0176
Pages
168–174
Publication Date
2026-04-16
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSIONS: Dentists who graduated more recently had a higher level of knowledge and awareness about anaphylaxis and its treatment compared to other groups.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: The aim of this study was to evaluate the knowledge and awareness of dentists about anaphylaxis, which develops suddenly and sometimes reaches life-threatening dimensions, and requires rapid and effective intervention.
📊
Key Findings & Data:MATERIAL AND METHODS: A questionnaire consisting of 20 questions was administered to all dentists who volunteered to participate in the study and completed their dental education in Türkiye.
💡
Conclusion & Impact:CONCLUSIONS: Dentists who graduated more recently had a higher level of knowledge and awareness about anaphylaxis and its treatment compared to other groups.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Anafilaksi · Diş Hekimi · Anestezi.

Abstract

OBJECTIVE: The aim of this study was to evaluate the knowledge and awareness of dentists about anaphylaxis, which develops suddenly and sometimes reaches life-threatening dimensions, and requires rapid and effective intervention. MATERIAL AND METHODS: A questionnaire consisting of 20 questions was administered to all dentists who volunteered to participate in the study and completed their dental education in Türkiye. This questionnaire form did not contain any information about the identity of the participants. Four questions in the questionnaire were related to the demographic characteristics of the participants, four questions were related to their daily clinical practice, and the remaining 12 questions were related to the diagnosis and treatment of anaphylaxis. The questionnaires were physically given to all participants who agreed to take part in the study and were collected by the researchers after the questionnaire was completed. RESULTS: A total of 228 dentists participated in the survey. 18-24 and 25-32 age groups were more likely to answer ''Epinephrine'' to the question ''Which drug is the first drug of choice in anaphylaxis'' (p=0.001). All participants in the 33-47 age group answered ''I don't know'' to the question ''Which route should epinephrine be administered in the treatment of anaphylaxis'' (p=0.001).'' To the question "Have you read any literature, book chapters or guidelines on the diagnostic criteria and treatment of anaphylaxis after graduation from dental school or after your specialty training?", all of those in the 33-47 age group answered "I have not, I think my knowledge is sufficient" (p=0.0001). CONCLUSIONS: Dentists who graduated more recently had a higher level of knowledge and awareness about anaphylaxis and its treatment compared to other groups.

Özet

AMAÇ: Bu çalışma ile ani gelişen ve zaman zaman hayatı tehdit eden boyutlara da ulaşabilen, hızlı ve etkin müdahale gerektiren anafilaksi durumu hakkında diş hekimlerinin bilgi ve farkındalığının değerlendirilmesi amaçlanmıştır. GEREÇ VE YÖNTEM: Çalışmaya katılmaya gönüllü olan diş hekimliği eğitimini Türkiye’de tamamlamış tüm diş hekimlerine 20 sorudan oluşan bir anket formu doldurtuldu. Bu anket formunda katılımcıların kimlik bilgilerine dair herhangi bilgi bulunmamaktadır. Anketteki 4 soru katılımcıların demografik özellikleri ile ilgili, 4 soru günlük klinik pratikleri ile ilgili iken geriye kalan 12 soru anafilaksi tanı ve tedavisi ilgili sorulardan oluşmaktadır. Çalışmada yer almaya kabul eden tüm katılımcılara anketler fiziken verilmiş ve anket tamamlandıktan sonra araştırmacılardan tarafından toplanmıştır. BULGULAR: Toplamda 228 diş hekimi ankete katılım gösterdi.18-24 ve 25-32 yaş grubundakiler daha yüksek anafilakside ilk tercih edilen ilacın hangisi olduğu sorusuna ‘’Epinefrin ‘’ cevabını verdiler (p=0,001). Anafilaksi tedavisinde epinefrinin hangi yol ile uygulanması gerektiği sorusuna 33 - 47 yaş grubundakilerin tamamı bilmiyorum cevabını verdi (p=0,001).’’ “Diş hekimliği fakültesinden mezuniyet veya Uzmanlık eğitiminiz sonrasında anafilaksi tanı kriterleri ve tedavisi konusunda herhangi bir literatür, kitap bölümü veya rehber okudunuz mu?’’ sorusuna 33-47 yaş grubundakilerin tamamının “Okumadım, bilgimin yeterli olduğunu düşünüyorum” cevabını verdi (p=0,0001). SONUÇ: Mezuniyetleri üzerinden daha kısa süre geçen diş hekimlerinin anafilaksi ve tedavisi hakkındaki bilgi ve farkındalık seviyesi diğer gruplara göre daha yüksektir.

🔖

Cite This Article

Akçaalan, Y., Yıldız, B., Özkaranfil, Ç., Açıkmeşe, İ., Orhan, K. (2026). EVALUATION OF THE EXPERIENCE AND KNOWLEDGE LEVELS OF DENTISTS ABOUT ANAPHYLAXIA AND TREATMENT, SURVEY STUDY. Kocatepe Tıp Dergisi, Cilt: 27 Sayı: 2, 168–174. https://doi.org/10.18229/kocatepetip.1673761

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472.
  2. Muraro A, Worm M, Alviani C, et al. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022;77(2):357-77.
  3. Rossi CM, Lenti MV, Di Sabatino A. Adult anaphylaxis: A state-of-the-art review. Eur J Intern Med. 2022;100:5-12.
  4. Bilò MB, Martini M, Tontini C, et al. Anaphylaxis. Eur Ann Allergy Clin Immunol. 2021;53(1):4-17.
  5. Tanno LK, Bierrenbach AL, Simons FER, et al. Critical view of anaphylaxis epidemiology: open questions and new perspectives. Allergy Asthma Clin Immunol. 2018;14(1):2.
  6. Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global Trends in Anaphylaxis Epidemiology and Clinical Implications. J Allergy Clin Immunol Pract. 2020;8(4):1169-76.
  7. Mertes PM, Tajima K, Regnier-Kimmoun MA, et al. Perioperative anaphylaxis. Med Clin North Am. 2010;94(4):761-89.
  8. Simons FER. Anaphylaxis: Recent advances in assessment and treatment. J Allergy Clin Immunol. 2009;124(4):625-36.
  9. Janas-Naze A, Osica P. The incidence of lidocaine allergy in dentists: an evaluation of 100 general dental practitioners. Int J Occup Med Environ Health. 2019;32(3):333-9.
  10. Fisher MM, Pennington JC. Allergy to local anaesthesia. Br J Anaesth. 1982;54(8):893-4.
  11. Kennedy KS, Cave RH. Anaphylactic reaction to lidocaine. Arch Otolaryngol Head Neck Surg. 1986;112(6):671-3.
  12. Ribeiro MLKK, Chong Neto HJ, Rosario Filho NA. Diagnosis and treatment of anaphylaxis: there is an urgent needs to implement the use of guidelines. Einstein (Sao Paulo). 2017;15(4):500-6.
  13. Krishnamurthy M, Venugopal NK, Leburu A, et al. Knowledge and attitude toward anaphylaxis during local anesthesia among dental practitioners in Chennai -a cross-sectional study. Clin Cosmet Investig Dent. 2018;10:117-21.
  14. Altman AM, Camargo CA, Simons FER, et al. Anaphylaxis in America: A national physician survey. J Allergy Clin Immunol. 2015;135(3):830-3.
  15. Arga M, Topal E, Yılmaz S ve ark. Healthcare workers` knowledge level regarding anaphylaxis and usage of epinephrine auto-injectors. Turk J Pediatr. 2021;63(3):372-83.
  16. Wood JP, Traub SJ, Lipinski C. Safety of epinephrine for anaphylaxis in the emergency setting. World J Emerg Med. 2013;4(4):245.
  17. Rutkowski K, Wagner A, Rutkowski R, et al. Alpha-gal syndrome: An emerging cause of food and drug allergy. Clin Exp Allergy. 2020;50(8):894-903.
  18. Wilson JM, Platts-Mills TAE. Red meat allergy in children and adults. Curr Opin Allergy Clin Immunol. 2019;19(3):229-35.
  19. Kanwar M, Irvin CB, Frank JJ, et al. Confusion about epinephrine dosing leading to iatrogenic overdose: a life- threatening problem with a potential solution. Ann Emerg Med. 2010;55(4):341-4.
  20. Hoyle JD, Davis AT, Putman KK, et al. Medication dosing errors in pediatric patients treated by emergency medical services. Prehospital emergency care. 2012;16(1):59-66.
  21. Simons FER, Ardusso LRF, Bilò MB, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4(2):13-37.
  22. Burks AW, Tang M, Sicherer S, et al. ICON: food allergy. J Allergy Clin Immunol. 2012;129(4):906-20.
  23. NIAID-Sponsored Expert Panel; Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID- sponsored expert panel. J Allergy Clin Immunol. 2010;126(6):1-58.
  24. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126(3):477-80.